HAVCR2 and neoplasm: In a study documenting the upregulation of TIM-3 on tumors of mice having developed resistance to PD-1 blockade, the sequential addition of a TIM-3 inhibitor was shown to recover immune control of the tumor, suggesting the potential benefit of such an approach [186].